Can't do the math without knowing the royalty rates, I hope they are higher than in the past.
Announced. I am assuming they are getting better royalty rates on these newer deals. Rates were quite bad on the early deals.
With Baxter, Roche, Pfizer , JNJ and now Abbvie, can Amgen be far behind?
I continue to have faith based upon the large insider ownership and the fact that these guys are not young, and are not selling.